ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Sage Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 24, 2021 GMT

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 24, 2021--

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced today that the Company will participate in a fireside chat at the Piper Sandler 33 rd Annual Virtual Healthcare Conference on December 1 at 8:30am ET.

A live webcast of the fireside chat can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

ADVERTISEMENT

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20211124005771/en/

CONTACT: Investor

Helen Rubinstein

315-382-3979

Helen.Rubinstein@sagerx.comMedia

Maureen L. Suda

617-949-4289

Maureen.Suda@sagerx.com

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH PHARMACEUTICAL HEALTH

SOURCE: Sage Therapeutics, Inc.

Copyright Business Wire 2021.

PUB: 11/24/2021 06:30 AM/DISC: 11/24/2021 06:32 AM

http://www.businesswire.com/news/home/20211124005771/en